はじめての方へショーケース価格
  1. 米国企業
  2. Vir Biotechnology, Inc.

Vir Biotechnology, Inc.VIR

時価総額
$13.1億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Cash and cash equivalents109437348849242
Short-term investments2743002171,5221,271
Cash and cash equivalents109437348849242
Restricted cash and cash equivalents, current6891313
Short-term investments2743002171,5221,271
Receivable from collaboration--773--
Restricted cash and cash equivalents, current6891313
Equity investments--1433210
Prepaid expenses and other current assets13287310453
Total current assets4037721,5632,5191,588
Intangible assets, net3634333323
Cash and cash equivalents109437348849242
Short-term investments2743002171,5221,271
Cash and cash equivalents109437348849242
Restricted cash and cash equivalents, current6891313
Short-term investments2743002171,5221,271
Receivable from collaboration--773--
Restricted cash and cash equivalents, current6891313
Equity investments--1433210
Prepaid expenses and other current assets13287310453
Total current assets4037721,5632,5191,588
Goodwill1717171717
Intangible assets, net3634333323
Property and equipment, net16184310696
Goodwill1717171717
Operating right-of-use assets-62878371
Property and equipment, net16184310696
Restricted cash and cash equivalents, noncurrent77776
Operating right-of-use assets-62878371
Long-term investments24-20124105
Restricted cash and cash equivalents, noncurrent77776
Other assets9931512
Long-term investments24-20124105
TOTAL ASSETS5129191,9542,8021,919
Other assets9931512
TOTAL ASSETS5129191,9542,8021,919
Accounts payable65766
Accrued and other liabilities-77237489104
Accounts payable65766
Deferred revenue, current66981665
Accrued and other liabilities-77237489104
Contingent consideration, current portion811---
Deferred revenue, current66981665
Total current liabilities5999341511175
Deferred revenue, noncurrent1344532
Accounts payable65766
Accrued and other liabilities-77237489104
Accounts payable65766
Deferred revenue, current66981665
Accrued and other liabilities-77237489104
Contingent consideration, current portion811---
Deferred revenue, current66981665
Total current liabilities5999341511175
Operating Lease, Liability, Noncurrent-67134124112
Deferred revenue, noncurrent1344532
Contingent consideration, noncurrent925232526
Operating Lease, Liability, Noncurrent-67134124112
Deferred tax liability-3183-
Contingent consideration, noncurrent925232526
Other long-term liabilities443814
TOTAL LIABILITIES88202522724329
Common Stock, Value, Issued00000
Additional paid-in capital7931,3851,5721,7101,829
Common Stock, Value, Issued00000
Accumulated other comprehensive loss-1-1-1-9-1
Additional paid-in capital7931,3851,5721,7101,829
(Accumulated deficit) retained earnings-368-667-139377-238
Accumulated other comprehensive loss-1-1-1-9-1
TOTAL STOCKHOLDERS’ EQUITY4247171,4322,0781,590
(Accumulated deficit) retained earnings-368-667-139377-238
TOTAL STOCKHOLDERS’ EQUITY----1,590
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY5129191,9542,8021,919
Cash and cash equivalents109437348849242
Short-term investments2743002171,5221,271
Cash and cash equivalents109437348849242
Restricted cash and cash equivalents, current6891313
Short-term investments2743002171,5221,271
Receivable from collaboration--773--
Restricted cash and cash equivalents, current6891313
Equity investments--1433210
Prepaid expenses and other current assets13287310453
Total current assets4037721,5632,5191,588
Intangible assets, net3634333323
Cash and cash equivalents109437348849242
Short-term investments2743002171,5221,271
Cash and cash equivalents109437348849242
Restricted cash and cash equivalents, current6891313
Short-term investments2743002171,5221,271
Receivable from collaboration--773--
Restricted cash and cash equivalents, current6891313
Equity investments--1433210
Prepaid expenses and other current assets13287310453
Total current assets4037721,5632,5191,588
Goodwill1717171717
Intangible assets, net3634333323
Property and equipment, net16184310696
Goodwill1717171717
Operating right-of-use assets-62878371
Property and equipment, net16184310696
Restricted cash and cash equivalents, noncurrent77776
Operating right-of-use assets-62878371
Long-term investments24-20124105
Restricted cash and cash equivalents, noncurrent77776
Other assets9931512
Long-term investments24-20124105
TOTAL ASSETS5129191,9542,8021,919
Other assets9931512
TOTAL ASSETS5129191,9542,8021,919
Accounts payable65766
Accrued and other liabilities-77237489104
Accounts payable65766
Deferred revenue, current66981665
Accrued and other liabilities-77237489104
Contingent consideration, current portion811---
Deferred revenue, current66981665
Total current liabilities5999341511175
Deferred revenue, noncurrent1344532
Accounts payable65766
Accrued and other liabilities-77237489104
Accounts payable65766
Deferred revenue, current66981665
Accrued and other liabilities-77237489104
Contingent consideration, current portion811---
Deferred revenue, current66981665
Total current liabilities5999341511175
Operating Lease, Liability, Noncurrent-67134124112
Deferred revenue, noncurrent1344532
Contingent consideration, noncurrent925232526
Operating Lease, Liability, Noncurrent-67134124112
Deferred tax liability-3183-
Contingent consideration, noncurrent925232526
Other long-term liabilities443814
TOTAL LIABILITIES88202522724329
Common Stock, Value, Issued00000
Additional paid-in capital7931,3851,5721,7101,829
Common Stock, Value, Issued00000
Accumulated other comprehensive loss-1-1-1-9-1
Additional paid-in capital7931,3851,5721,7101,829
(Accumulated deficit) retained earnings-368-667-139377-238
Accumulated other comprehensive loss-1-1-1-9-1
TOTAL STOCKHOLDERS’ EQUITY4247171,4322,0781,590
(Accumulated deficit) retained earnings-368-667-139377-238
TOTAL STOCKHOLDERS’ EQUITY----1,590
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY5129191,9542,8021,919